
Post herpetic Neuralgia Treatment Industry Research Report 2024
Description
Post herpetic Neuralgia Treatment Industry Research Report 2024
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Highlights
The global Post herpetic Neuralgia Treatment market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Post herpetic Neuralgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post herpetic Neuralgia Treatment.
The Post herpetic Neuralgia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Post herpetic Neuralgia Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post herpetic Neuralgia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine
Product Type Insights
Global markets are presented by Post herpetic Neuralgia Treatment type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Post herpetic Neuralgia Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Post herpetic Neuralgia Treatment segment by Type
Anticonvulsants
Skin Patch
Other
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Post herpetic Neuralgia Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Post herpetic Neuralgia Treatment market.
Post herpetic Neuralgia Treatment Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Post herpetic Neuralgia Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Post herpetic Neuralgia Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Post herpetic Neuralgia Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Post herpetic Neuralgia Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Post herpetic Neuralgia Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Post herpetic Neuralgia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
81 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Post herpetic Neuralgia Treatment by Type
- 2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
- 1.2.2 Anticonvulsants
- 1.2.3 Skin Patch
- 1.2.4 Other
- 2.3 Post herpetic Neuralgia Treatment by Distribution Channel
- 2.3.1 Market Value Comparison by Distribution Channel (2019 VS 2023 VS 2030)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Online Pharmacies
- 2.3.4 Retail Pharmacies
- 2.4 Assumptions and Limitations
- 3 Post herpetic Neuralgia Treatment Breakdown Data by Type
- 3.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Type (2019-2024)
- 3.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2025-2030)
- 4 Post herpetic Neuralgia Treatment Breakdown Data by Distribution Channel
- 4.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Distribution Channel (2019-2024)
- 4.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2019-2024)
- 5 Global Growth Trends
- 5.1 Global Post herpetic Neuralgia Treatment Market Perspective (2019-2030)
- 5.2 Global Post herpetic Neuralgia Treatment Growth Trends by Region
- 5.2.1 Global Post herpetic Neuralgia Treatment Market Size by Region: 2019 VS 2023 VS 2030
- 5.2.2 Post herpetic Neuralgia Treatment Historic Market Size by Region (2019-2024)
- 5.2.3 Post herpetic Neuralgia Treatment Forecasted Market Size by Region (2025-2030)
- 5.3 Post herpetic Neuralgia Treatment Market Dynamics
- 5.3.1 Post herpetic Neuralgia Treatment Industry Trends
- 5.3.2 Post herpetic Neuralgia Treatment Market Drivers
- 5.3.3 Post herpetic Neuralgia Treatment Market Challenges
- 5.3.4 Post herpetic Neuralgia Treatment Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue
- 6.1.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue (2019-2024)
- 6.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Players (2019-2024)
- 6.2 Global Post herpetic Neuralgia Treatment Industry Players Ranking, 2022 VS 2023 VS 2024
- 6.3 Global Key Players of Post herpetic Neuralgia Treatment Head office and Area Served
- 6.4 Global Post herpetic Neuralgia Treatment Players, Product Type & Application
- 6.5 Global Post herpetic Neuralgia Treatment Players, Date of Enter into This Industry
- 6.6 Global Post herpetic Neuralgia Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Post herpetic Neuralgia Treatment Market Size (2019-2030)
- 7.2 North America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 North America Post herpetic Neuralgia Treatment Market Size by Country (2019-2024)
- 7.4 North America Post herpetic Neuralgia Treatment Market Size by Country (2025-2030)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Post herpetic Neuralgia Treatment Market Size (2019-2030)
- 8.2 Europe Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Europe Post herpetic Neuralgia Treatment Market Size by Country (2019-2024)
- 8.4 Europe Post herpetic Neuralgia Treatment Market Size by Country (2025-2030)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size (2019-2030)
- 9.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Country (2019-2024)
- 9.4 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Country (2025-2030)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
- 10 Latin America
- 10.1 Latin America Post herpetic Neuralgia Treatment Market Size (2019-2030)
- 10.2 Latin America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2019-2024)
- 10.4 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2025-2030)
- 9.4 Mexico
- 9.5 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size (2019-2030)
- 11.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 11.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2019-2024)
- 11.4 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2025-2030)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
- 12 Players Profiled
- 11.1 Pfizer
- 11.1.1 Pfizer Company Detail
- 11.1.2 Pfizer Business Overview
- 11.1.3 Pfizer Post herpetic Neuralgia Treatment Introduction
- 11.1.4 Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2017-2022)
- 11.1.5 Pfizer Recent Development
- 11.2 Arbor Pharma
- 11.2.1 Arbor Pharma Company Detail
- 11.2.2 Arbor Pharma Business Overview
- 11.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Introduction
- 11.2.4 Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2017-2022)
- 11.2.5 Arbor Pharma Recent Development
- 11.3 Assertio Therapeutics
- 11.3.1 Assertio Therapeutics Company Detail
- 11.3.2 Assertio Therapeutics Business Overview
- 11.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Introduction
- 11.3.4 Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2017-2022)
- 11.3.5 Assertio Therapeutics Recent Development
- 11.4 Endo Pharma
- 11.4.1 Endo Pharma Company Detail
- 11.4.2 Endo Pharma Business Overview
- 11.4.3 Endo Pharma Post herpetic Neuralgia Treatment Introduction
- 11.4.4 Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2017-2022)
- 11.4.5 Endo Pharma Recent Development
- 11.5 Teikoku Pharma
- 11.5.1 Teikoku Pharma Company Detail
- 11.5.2 Teikoku Pharma Business Overview
- 11.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Introduction
- 11.5.4 Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2017-2022)
- 11.5.5 Teikoku Pharma Recent Development
- 11.6 Teva
- 11.6.1 Teva Company Detail
- 11.6.2 Teva Business Overview
- 11.6.3 Teva Post herpetic Neuralgia Treatment Introduction
- 11.6.4 Teva Revenue in Post herpetic Neuralgia Treatment Business (2017-2022)
- 11.6.5 Teva Recent Development
- 11.7 Mylan
- 11.7.1 Mylan Company Detail
- 11.7.2 Mylan Business Overview
- 11.7.3 Mylan Post herpetic Neuralgia Treatment Introduction
- 11.7.4 Mylan Revenue in Post herpetic Neuralgia Treatment Business (2017-2022)
- 11.7.5 Mylan Recent Development
- 11.8 Hengrui Medicine
- 11.8.1 Hengrui Medicine Company Detail
- 11.8.2 Hengrui Medicine Business Overview
- 11.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Introduction
- 11.8.4 Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2017-2022)
- 11.8.5 Hengrui Medicine Recent Development
- 13 Report Conclusion
- 14 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
- Table 4. Market Value Comparison by Distribution Channel (2019 VS 2023 VS 2030) & (US$ Million)
- Table 5. Global Post herpetic Neuralgia Treatment Market Size by Type (2019-2024) & (US$ Million)
- Table 6. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2019-2024)
- Table 7. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
- Table 8. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2025-2030)
- Table 9. Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2019-2024) & (US$ Million)
- Table 10. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2019-2024)
- Table 11. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2025-2030) & (US$ Million)
- Table 12. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2025-2030)
- Table 13. Global Post herpetic Neuralgia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
- Table 14. Global Post herpetic Neuralgia Treatment Market Size by Region (2019-2024) & (US$ Million)
- Table 15. Global Post herpetic Neuralgia Treatment Market Share by Region (2019-2024)
- Table 16. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
- Table 17. Global Post herpetic Neuralgia Treatment Market Share by Region (2025-2030)
- Table 18. Post herpetic Neuralgia Treatment Market Trends
- Table 19. Post herpetic Neuralgia Treatment Market Drivers
- Table 20. Post herpetic Neuralgia Treatment Market Challenges
- Table 21. Post herpetic Neuralgia Treatment Market Restraints
- Table 22. Global Top Post herpetic Neuralgia Treatment Manufacturers by Revenue (US$ Million) & (2019-2024)
- Table 23. Global Post herpetic Neuralgia Treatment Revenue Market Share by Manufacturers (2019-2024)
- Table 24. Global Post herpetic Neuralgia Treatment Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
- Table 25. Global Key Players of Post herpetic Neuralgia Treatment, Headquarters and Area Served
- Table 26. Global Post herpetic Neuralgia Treatment Manufacturers, Product Type & Application
- Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 28. Global Post herpetic Neuralgia Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
- Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
- Table 30. North America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 31. North America Post herpetic Neuralgia Treatment Market Size by Country (2019-2024) & (US$ Million)
- Table 32. North America Post herpetic Neuralgia Treatment Market Size by Country (2025-2030) & (US$ Million)
- Table 33. Europe Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 34. Europe Post herpetic Neuralgia Treatment Market Size by Country (2019-2024) & (US$ Million)
- Table 35. Europe Post herpetic Neuralgia Treatment Market Size by Country (2025-2030) & (US$ Million)
- Table 36. Asia-Pacific Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 37. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Country (2019-2024) & (US$ Million)
- Table 38. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Country (2025-2030) & (US$ Million)
- Table 39. Latin America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 40. Latin America Post herpetic Neuralgia Treatment Market Size by Country (2019-2024) & (US$ Million)
- Table 41. Latin America Post herpetic Neuralgia Treatment Market Size by Country (2025-2030) & (US$ Million)
- Table 42. Middle East & Africa Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 43. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2019-2024) & (US$ Million)
- Table 44. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2025-2030) & (US$ Million)
- Table 45. Pfizer Company Detail
- Table 46. Pfizer Business Overview
- Table 47. Pfizer Post herpetic Neuralgia Treatment Product
- Table 48. Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2017-2022) & (US$ Million)
- Table 49. Pfizer Recent Development
- Table 50. Arbor Pharma Company Detail
- Table 51. Arbor Pharma Business Overview
- Table 52. Arbor Pharma Post herpetic Neuralgia Treatment Product
- Table 53. Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2017-2022) & (US$ Million)
- Table 54. Arbor Pharma Recent Development
- Table 55. Assertio Therapeutics Company Detail
- Table 56. Assertio Therapeutics Business Overview
- Table 57. Assertio Therapeutics Post herpetic Neuralgia Treatment Product
- Table 58. Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2017-2022) & (US$ Million)
- Table 59. Assertio Therapeutics Recent Development
- Table 60. Endo Pharma Company Detail
- Table 61. Endo Pharma Business Overview
- Table 62. Endo Pharma Post herpetic Neuralgia Treatment Product
- Table 63. Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2017-2022) & (US$ Million)
- Table 64. Endo Pharma Recent Development
- Table 65. Teikoku Pharma Company Detail
- Table 66. Teikoku Pharma Business Overview
- Table 67. Teikoku Pharma Post herpetic Neuralgia Treatment Product
- Table 68. Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2017-2022) & (US$ Million)
- Table 69. Teikoku Pharma Recent Development
- Table 70. Teva Company Detail
- Table 71. Teva Business Overview
- Table 72. Teva Post herpetic Neuralgia Treatment Product
- Table 73. Teva Revenue in Post herpetic Neuralgia Treatment Business (2017-2022) & (US$ Million)
- Table 74. Teva Recent Development
- Table 75. Mylan Company Detail
- Table 76. Mylan Business Overview
- Table 77. Mylan Post herpetic Neuralgia Treatment Product
- Table 78. Mylan Revenue in Post herpetic Neuralgia Treatment Business (2017-2022) & (US$ Million)
- Table 79. Mylan Recent Development
- Table 80. Hengrui Medicine Company Detail
- Table 81. Hengrui Medicine Business Overview
- Table 82. Hengrui Medicine Post herpetic Neuralgia Treatment Product
- Table 83. Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2017-2022) & (US$ Million)
- Table 84. Hengrui Medicine Recent Development
- Table 85. Pfizer Company Information
- Table 86. Pfizer Business Overview
- Table 87. Pfizer Post herpetic Neuralgia Treatment Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million)
- Table 88. Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million) Portfolio
- Table 89. Pfizer Recent Development
- Table 90. Arbor Pharma Company Information
- Table 91. Arbor Pharma Business Overview
- Table 92. Arbor Pharma Post herpetic Neuralgia Treatment Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million)
- Table 93. Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million) Portfolio
- Table 94. Arbor Pharma Recent Development
- Table 95. Assertio Therapeutics Company Information
- Table 96. Assertio Therapeutics Business Overview
- Table 97. Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million)
- Table 98. Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million) Portfolio
- Table 99. Assertio Therapeutics Recent Development
- Table 100. Endo Pharma Company Information
- Table 101. Endo Pharma Business Overview
- Table 102. Endo Pharma Post herpetic Neuralgia Treatment Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million)
- Table 103. Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million) Portfolio
- Table 104. Endo Pharma Recent Development
- Table 105. Teikoku Pharma Company Information
- Table 106. Teikoku Pharma Business Overview
- Table 107. Teikoku Pharma Post herpetic Neuralgia Treatment Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million)
- Table 108. Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million) Portfolio
- Table 109. Teikoku Pharma Recent Development
- Table 110. Teva Company Information
- Table 111. Teva Business Overview
- Table 112. Teva Post herpetic Neuralgia Treatment Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million)
- Table 113. Teva Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million) Portfolio
- Table 114. Teva Recent Development
- Table 115. Mylan Company Information
- Table 116. Mylan Business Overview
- Table 117. Mylan Post herpetic Neuralgia Treatment Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million)
- Table 118. Mylan Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million) Portfolio
- Table 119. Mylan Recent Development
- Table 120. Hengrui Medicine Company Information
- Table 121. Hengrui Medicine Business Overview
- Table 122. Hengrui Medicine Post herpetic Neuralgia Treatment Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million)
- Table 123. Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2019-2024) & (US$ Million) Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.